A detailed history of Retirement Group, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Retirement Group, LLC holds 500 shares of VKTX stock, worth $26,785. This represents 0.02% of its overall portfolio holdings.

Number of Shares
500
Previous 500 -0.0%
Holding current value
$26,785
Previous $9,000 355.56%
% of portfolio
0.02%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$9.24 - $19.64 $4,620 - $9,820
500 New
500 $9,000
Q2 2023

Aug 15, 2023

BUY
$14.84 - $24.79 $13,356 - $22,311
900 Added 75.0%
2,100 $34,000
Q4 2022

Feb 15, 2023

BUY
$2.72 - $9.4 $3,264 - $11,280
1,200 New
1,200 $11,000
Q4 2020

Feb 22, 2021

SELL
$5.3 - $6.71 $10,600 - $13,420
-2,000 Closed
0 $0
Q2 2020

Sep 08, 2021

SELL
$4.35 - $8.08 $869 - $1,616
-200 Reduced 9.09%
2,000 $14,000
Q4 2019

Aug 30, 2021

BUY
$6.38 - $8.73 $14,036 - $19,206
2,200 New
2,200 $18,000

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $4.11B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Retirement Group, LLC Portfolio

Follow Retirement Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Retirement Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Retirement Group, LLC with notifications on news.